Last reviewed · How we verify

multimodal analgesia and vitamin B

Ain Shams University · Phase 1 active Small molecule Quality 0/100

multimodal analgesia and vitamin B is a Small molecule drug developed by Ain Shams University. It is currently in Phase 1 development. Also known as: neuroton tablets.

At a glance

Generic namemultimodal analgesia and vitamin B
Also known asneuroton tablets
SponsorAin Shams University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about multimodal analgesia and vitamin B

What is multimodal analgesia and vitamin B?

multimodal analgesia and vitamin B is a Small molecule drug developed by Ain Shams University.

Who makes multimodal analgesia and vitamin B?

multimodal analgesia and vitamin B is developed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).

Is multimodal analgesia and vitamin B also known as anything else?

multimodal analgesia and vitamin B is also known as neuroton tablets.

What development phase is multimodal analgesia and vitamin B in?

multimodal analgesia and vitamin B is in Phase 1.

Related